Skip to main content
Equibles

GHC · GAROFALO HEALTH CARE S.P.A. · Financials

Use GHC with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research GHC.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
5.3800 EUR -0.0400 (-0.74%) At close · Oct 6
Rebalance outlook locked
Market Cap
481.03M EUR
Shares
88.43M

Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.

Pull these statements through the financial statements API or MCP →

Browse captured authority reports and their original financial labels

Revenue
487.08M +3.5%
FY2025 Revenue FY2020–FY2025
Net Income
23.41M +7.9%
FY2025 Net Income FY2020–FY2025
Operating Margin
9.27% -0.1pp
FY2025 Operating Margin FY2020–FY2025
Operating Cash Flow
49.04M +40.1%
FY2025 Operating Cash Flow FY2020–FY2025

Chart any reported metric, KPI or segment over time — the full statement history lives here

Income Statement Balance Sheet Cash Flow All Metrics
Annual Quarterly
Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020
EUR 487.08M 470.71M 368.7M 322.58M 283.67M 210.85M
EUR 45.15M 44.13M 39.23M 31.67M 28.23M 15.49M
EUR 11.81M 14.77M 10.79M 4.55M 4.51M 2.76M
EUR 33.96M 30.69M 28.93M 27.37M 23.99M 13.02M
EUR 10.39M 8.84M 8.06M 5.94M 5.15M 1.24M
EUR 23.41M 21.7M 20.8M 21.43M 18.83M 11.78M
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.

Capital Returned to Shareholders

Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2020–FY2025: 10.23M in buybacks, 7.59M in dividends.

Debt Profile

Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.

Instrument and agreement coverage is incomplete. Additional filings are awaiting review.

Covenants

Covenant terms have not yet been verified for this profile.

The balance figures do not establish whether covenants apply or whether the company complies with them.

Loans, facilities and notes

The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.